EASL highlights: the hepatitis C story continues
This article was originally published in Scrip
Executive Summary
Despite hepatitis C being essentially 'cured', there was still plenty of action at last week's European Association for the Study of the Liver (EASL) annual meeting in Vienna as companies work to improve treatment durations and improve costs.